Browse > Article
http://dx.doi.org/10.1007/s10059-009-0037-8

Synthesis of Reconstituted High Density Lipoprotein (rHDL) Containing apoA-I and apoC-III: the Functional Role of apoC-III in rHDL  

Cho, Kyung-Hyun (School of Biotechnology, Aging-associated Vascular Disease Research Center, Yeungnam University)
Publication Information
Molecules and Cells / v.27, no.3, 2009 , pp. 291-297 More about this Journal
Abstract
Apolipoprotein (apo) C-III is a marker protein of triacylglycerol (TG)-rich lipoproteins and high-density lipoproteins (HDL), and has been proposed as a risk factor of coronary heart disease. To compare the physiologic role of reconstituted HDL (rHDL) with or without apoC-III, we synthesized rHDL with molar ratios of apoA-I:apoC-III of 1:0, 1:0.5, 1:1, and 1:2. Increasing the apoC-III content in rHDL produced smaller rHDL particles with a lower number of apoA-I molecules. Furthermore, increasing the molar ratio of apoC-III in rHDL enhanced the surfactant-like properties and the ability to lyse dimyristoyl phosphatidylcholine. Furthermore, rHDL containing apoC-III was found to be more resistant to particle rearrangement in the presence of low-density lipoprotein (LDL) than rHDL that contained apoA-I alone. In addition, the lecithin:cholesterol acyltransferase (LCAT) activation ability was reduced as the apoC-III content of the rHDL increased; however, the CE transfer ability was not decreased by the increase of apoC-III. Finally, rHDL containing apoC-III aggravated the production of MDA in cell culture media, which led to increased cellular uptake of LDL. Thus, the addition of apoC-III to rHDL induced changes in the structural and functional properties of the rHDL, especially in particle size and rearrangement and LCAT activation. These alterations may lead to beneficial functions of HDL, which is involved in anti-atherogenic properties in the circulation.
Keywords
apolipoprotein A-I; apolipoprotein C-III; cholesterol acyltransferase; cholesteryl ester transfer protein; high-density lipoprotein; lecithin;
Citations & Related Records
Times Cited By KSCI : 2  (Citation Analysis)
Times Cited By Web Of Science : 18  (Related Records In Web of Science)
연도 인용수 순위
1 Breyer, E.D., Le, N.A., Li, X., Martinson, D., and Brown, W.V. (1999). Apolipoprotein C-III displacement of apolipoprotein E from VLDL:effect of particle size. J. Lipid Res. 40, 1875-1882
2 Ooi, E.M.M., Barrett, P.H.R., Chan, D.C., and Watts, G.F. (2008). Apolipoprotein C-III:understanding an emerging cardiovascular risk factor. Clin. Sci. 114, 611-624   DOI   PUBMED   ScienceOn
3 Staros, J.V. (1982). N-hydroxysulfosuccinimide active esters: bis Nhydroxysulfosuccinimide) esters of two dicarboxylic acids are hydrophilic, membrane-impermeant, protein cross-linkers. Biochemistry 21, 3950-3955   DOI   PUBMED   ScienceOn
4 Cho, K.H., Lee, J.Y., Choi, M.S., Cho, J.M., Lim, J.S., and Park, Y.B.(1998). A peptide from hog plasma that inhibits human cholesteryl ester transfer protein. Biochim. Biophys. Acta 30, 133-144   DOI   ScienceOn
5 Pownall, H.J., Massey, J.B., Kusserow, S.K., and Gotto, A.M., Jr. (1978). Kinetics of lipid-protein interactions: interaction of apolipoprotein A-I from human plasma high density lipoproteins with phosphatidylcholines. Biochemistry 17, 1183-1188   DOI   PUBMED   ScienceOn
6 Matz, C.E., and Jonas, A. (1982). Micellar complexes of human apolipoprotein A-I with phosphatidylcholines and cholesterol prepared from cholate-lipid dispersions. J. Biol. Chem 257, 4535-4540   PUBMED
7 Lewis, G.F., and Rader, D.J. (2005). New insights into the regulation of HDL metabolism and reverse cholesterol transport. Circ. Res. 96, 1221-1232   DOI   PUBMED   ScienceOn
8 Ting, H.J., Stice, J.P., Schaff, U.Y., Hui, D.Y., Rutledge, J.C., Knowlton, A.A., Passerini, A.G., and Simon, S.I. (2007). Triglyceride-rich lipoproteins prime aortic endothelium for an enhanced inflammatory response to tumor necrosis factor-alpha. Circ. Res. 100, 381-390   DOI   PUBMED   ScienceOn
9 Sacks, F.M., Alaupovic, P., Moye, L.A., Cole, T.G., Sussex, B., Stampfer, M.J., Pfeffer, M.A., and Braunwald, E. (2000). VLDL, Apolipoproteins B, CIII, and E, and risk of recurrent coronary events in the cholesterol and recurrent events (CARE). Trial. Circulation 102, 1886-1892   DOI   PUBMED   ScienceOn
10 Hodis, H.N. (1999). Triglyceride-rich lipoprotein remnant particles and risk of atherosclerosis. Circulation 99, 2852-2854   DOI   PUBMED   ScienceOn
11 Jonas, A., Kezdy, K.E., and Wald, J.H. (1989). Defined apolipoprotein A-I conformations in reconstituted high density lipoprotein discs. J. Biol. Chem. 264, 4818-4824   PUBMED
12 Jonas, A. (1991). Lecithin-cholesterol acyltransferase in the metabolism of high-density lipoproteins. Biochim. Biophys. Acta 1084, 205-220   DOI   PUBMED
13 Lee, S., Campos, H., Moye, L.A., and Sacks, F.M. (2003). LDL containing apolipoprotein C-III is an independent risk factor for coronary events in diabetic patients. Arterioscler. Thromb. Vasc. Biol. 23, 853-858   DOI   PUBMED   ScienceOn
14 Sparks, D.L., and Pritchard, P.H. (1989). Transfer of cholesteryl ester into high density lipoprotein by cholesteryl ester transfer protein: effect of HDL lipid and apoprotein content. J. Lipid. Res. 30, 1491-1498   PUBMED
15 Barter, P.J., Nicholls, S., Rye, K.A., Anantharamaiah, G.M., Naval, M., and Fogelman, A.M. (2004). Antiinflammatory properties of HDL. Circ. Res. 9, 764-772   DOI   PUBMED   ScienceOn
16 Cho, K.H., and Jonas, A. (2000). A key point mutation (V156E) affects the structure and functions of human apolipoprotein A-I. J. Biol. ChemK 275, 26821-26827   DOI
17 Onat, A., Hergenc, G., Sansoy, V., Fobker, M., Ceyhan, K., Toprak, S., and Assmann, G. (2003). Apolipoprotein C-III, a strong discriminant of coronary risk in men and a determinant of the metabolic syndrome in both genders. Atherosclerosis 168, 81-89   DOI   ScienceOn
18 Ginsberg, H.N., Le, N.A., Goldberg, I.J., Gibson, J.C., Rubinstein, A., Wang-Iverson, P., Norum, R., and Brown, W.V. (1986). Apolipoprotein B metabolism in subjects with deficiency of apolipoproteins CIII and AI. Evidence that apolipoprotein CIII inhibits catabolism of triglyceride-rich lipoproteins by lipoprotein lipase in vivo. J. Clin. Invest. 78, 1287-1295   DOI   PUBMED
19 Markwell, M.A., Haas, S.M., Bieber, L.L., and Tolbert, N.E. (1978). A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples. Anal. BiochemK 87, 206-210   DOI   ScienceOn
20 Park, S.H., Park, J.E., Kim, Y.O., Song, K.J., Kim, S.S., Kim, J.R., Choi, I., Kim, J.J., and Cho, K.H. (2008). Function and composition of high-density lipoprotein were severely impaired in an oliguric phase of hemorrhagic fever with renal syndrome patients. Clin. Biochem. 41, 56-64   DOI   PUBMED   ScienceOn
21 Brown, M.L., Inazu, A., Hesler, C.B., Agellon, L.B., Mann, C., Whitlock, M.E., Marcel, Y.L., Milne, R.W., Koizumi, J., Mabuchi, H., et al. (1989). Molecular basis of lipid transfer protein deficiency in a family with increased high-density lipoproteins. Nature 342, 448-51   DOI   PUBMED   ScienceOn
22 Brousseau, M.E. (2005). Emerging role of high-density lipoprotein in the prevention of cardiovascular disease. Drug Discov. Today 10, 1095-1101   DOI   ScienceOn
23 Jonas, A., Sweeny, S.A., and Herber, P.N. (1984). Discoidal complexes of A and C apolipoproteins with lipids and their reactions with lecithin:cholesterol acyltransferase. J. Biol. Chem. 259, 6369-6375   PUBMED
24 Wang, C.S., McConathy, W.J., Kloer, H.U., and Alaupovic, P. (1985). Modulation of lipoprotein lipase activity by apolipoproteins. J. Clin. Invest. 75, 384-390   DOI   PUBMED
25 Jonas, A., Wald, J.H., Toohill, K.L., Krul, E.S., and Kezdy, K.E. (1990). Apolipoprotein A-I structure and lipid properties in homogeneous, reconstituted spherical and discoidal high density lipoproteins. J. Biol. Chem. 265, 22123-22129   PUBMED
26 Shachter, N.S. (2001). Apolipoproteins C-I and C-III as important modulators of lipoprotein metabolism. Curr. Opin. Lipidol. 12, 297-304   DOI   PUBMED   ScienceOn
27 Cho, K.H., Shin, D.G., Baek, S.H., and Kim, J.R. (2009). Myocardial infarction patients showed altered lipoprotein properties and functions when compared with stable angina pectoris patients. Exp. Mol. Med. 41, 67-76   DOI   PUBMED   ScienceOn
28 Ginsberg, H.N., Jones, J., Blaner, W.S., Thomas, A., Karmally, W., Fields, L., Blood, D., and Begg, M.D. (1995). Association of postprandial triglyceride and retinyl plalmitate responses with newly diagnosed exercise-induced myocardial ischemia in middle-aged men and women. Arterioscler. Thromb. Vasc. Biol. 15, 1829-1838   DOI   PUBMED
29 Han, J.M., Jeong, T.S., Lee, W.S., Choi, I., and Cho, K.H. (2005). Structural and functional properties of V156K and A158E mutants of apolipoprotein A-I in the lipid-free and lipid-bound states. J. Lipid. Res. 46, 589-596   DOI   PUBMED   ScienceOn
30 Nishida, H.I., Nakanishi, T., Yen, E.A., Arai, H., Yen, F.T., and Nishida, T. (1986). Nature of the enhancement of lecithincholesterol acyltransferase reaction by various apolipoproteins. J. Biol. Chem. 261, 12028-12035   PUBMED
31 Bruns, G.A., Karathanasis, S.K., and Breslow, J.L. (1984). Human apolipoprotein A-I--C-III gene complex is located on chromosome 11. Arteriosclerosis 4, 97-102   DOI   PUBMED